StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
ResMed (RMD) Gains Over 17% on FQ2 Earnings Beat, Ratings Upgrades and Price Target Boost
January 23, 2018 12:13 PM
ResMed (NYSE: RMD) is seeing buyers bid up shares today, gaining 17% on the session, after ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Momentum Movers
Trader Talk
Next Articles
Northland Capital Markets Upgrades ResMed (RMD) to Market Perform
January 23, 2018 8:50 AM
Needham & Company Upgrades ResMed (RMD) to Hold
January 23, 2018 7:34 AM
ResMed (RMD) PT Raised to $76 at Barclays
January 23, 2018 5:18 AM
ResMed (RMD) Tops Q2 EPS by 22c, Beats on Revenues
January 22, 2018 4:06 PM
